1. Better understanding of newly approved psychotropic medications;
2. Better understanding of new indications for previously approved psychotropic medications; and
3. Better understanding of existing pharmacological treatment-challenges.
1. https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
2. http://www.accessdata.fda.gov/scripts/cder/daf/
3. http://www.pre.ethics.gc.ca/pdf/eng/tcps2-2014/TCPS_2_FINAL_Web.pdf
Despite an urgent need for more effective and better tolerated psychopharmacological treatment options, the last years have seen few additions to our pharmacological treatment options. I will review new treatment options as well as new formulations and new indications for previously approved medications.